Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
270 participants
OBSERVATIONAL
2023-04-01
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413
Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou
NCT02504528
Huang-long Zhi-xiao Granule Improves the Control Rate of Chronic Persistent of Asthma
NCT05841901
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
acute exacerbation CARAS
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
chronic persistence CARAS
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
clinical control CARAS
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
acute exacerbation BA
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
chronic persistence BA
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
clinical control BA
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
intermittent AR
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
persistent AR
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
healthy individuals
Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.
questionnaire survey
subjects fill out questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire survey
subjects fill out questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence, or wind-heat offending the lung evidence;
* Age 18 to 80 years;
* Voluntarily accepted the study and signed an informed consent form;
* Not participated in other clinical studies within 1 month before enrollment.
Exclusion Criteria
* Patients who are participating in other drug trials;
* Patients with a combination of other serious systemic diseases;
* Pregnant or lactating women;
* Patients with confusion, disorders of consciousness, dementia, and various psychiatric disorders.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henan University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Henan University of Chinese Medicine
Henan, Zhengzhou, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EBC biomarkers in CARAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.